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Conclusions: Prolongation of the QT interval by A is only beneficial if QTpeak and TpTe 
are increased proportionally. Risk of cardiac death is increased if the QT prolongation is 
mamly due to an Increase in TpTe. 
1115-11 Markers of Central Modification of the Sympathetic 
Nervous System Activity in Humans 
Vladimir Shusterman Peter J. Jannetta, Benhur Aysin, Maksim Glukhovskoy, lrmute 
Usiene. University of Pinsburgh, Pinsburgh, PA, Allegheny General Hospital, Pittsburgh, 
PA 
Brainstem centers of the sympathetic nervws system activity (SNSA) located in the ros- 
tral ventro-lateral medulla (RVLM) play an important role in SNSA homeostasis. We 
hypothesized that mechanical stimulation of the RVLM neurons would modify SNSA and 
examined the effects of the stimulation on heart rate (HR) and HRV. 
Methods. In 10 patients (age: 54*14y, Bfemales), the lefl (7patients) or the right 
(3patients) side of the brainstem was exposed during neurosurgery, and a mechanical 
stimulation (duration: lmin, frequency: l-2Hz) of the RVLM area was performed consec- 
utively at 3.7sites using a Z-mm metallic ball. RR-intervals between the sinus beats were 
extracted from the continuous ECG recordings, and the low (LFP:.04-.15Hz) and high 
(HFP:.l5-.4Hz) frequency powers of HRV. and the ratio LFPiHFP were calculated in con- 
secutive 5min intervals. 
Results. HR increased during the stimulation of RVLM both on the lefl and the right side 
from 81+4 to 66+2bpm (p=.Ol) (Figure). LFP and HFP tended lo decrease slightly (13% 
and 10%; p=.3 and .08, respectively). but LFP/HFP did not change (p=.7). 
Conclusions. Central sympathetic stimulation in anesthetized patients with controlled 
respiration increases HR, but does not change the spectral distribution of HRV as 
reflected by the ratio LFP/HFP. This suggests that HR is a mixa reliable marker of central 
SNSA modifications in this setting than spectral HRV indices. 
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1115-12 Prevalent Low-Frequency Oscillation of Heart Rate Is 
the Strongest Risk Stratifier Independent of All 
Available Mortality Predictors in the Placebo Population 
of EMIAT Trial 
Dan Wichterle, Jan Simek, A. John Cam”, Marek Malik, St George’s Hospital Medical 
School. London, UnItad Kingdom, General University Hospital, Prague, Czech Republic 
Background: A powerful new post-infarctjon risk stratifier (prevalent low-frequency oscil- 
IatiOn, PLF) was shown to be independent of LVEF, heart rate variability (HRV) index and 
Turbulence Slope (TS) in the placebo population of EMIAT trial. This study investigated 
whether it IS also independent of other clinical and electrophysiological risk factors. 
Methods: RR interval series of all 5-mln segments of baseline Halter recordings (n&33) 
were analysed by the method of averaging periodograms according to Welch with fre- 
quency resolution of l/60 Hz. Maximum and distinct peak within frequency range of 
0.033 - 0.133 Hz was detected in each spectrum and their frequencies were averaged to 
obtain the PLF index. Cox’s univariate and multivariate regression analysis was used to 
establish the association of LVEF I: 30%, age 2 65. previous MI, NYHA Class 2 2, 
present DM, QRS > 100 ms, no thrombolysis for index MI, absence of beta-blocker treat- 
ment at baseline, mean RR r: 800 ms, HRV Index < 20, low-frequency spectral power 
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(LF) 5 130 ms’, high-frequency spectral power (HF) i 30 ms’, Tu~I~~lence Onset (TO) t 
0 %, TS < 2.5 “s/RR, and PLF 2 0.1 Hz with all-cause mortality within mean 614 days 
follow-up. All significant univariate predictors were included into multivariate analysis. 
Cut-off points for continuous variables ware set at 40% sensitivity or as previously estab- 
lished. 
Results: PLF t 0.1 Hz had a positive predictive accuracy of 42% and univariate relative 
risk (RR) of 6.3 (95% Cl 3.8 - 10.4, p = lo’*) for all-cause mortality. In multivariate anal- 
ysis, PLF remained the most powerful predictor (RR = 4.0, 95% Cl 1.9 - 8.5, p = 0.0002) 
followed by HF (RR = 2.7, 95% Cl 1.1 - 6.3, p = 0.03), previous Ml (RR = 2.2, 95% Cl 1.2 
4.0, p = O.Ol), and QRS duration (RR = 1.9, 95% Cl 1.0 3.6, p L 0.05). 
Conclusion: In post-infarction patients, PLF is a very strong predictor of all-cause mor- 
tality, which is independent of other available risk factors. 
ORAL CONTRIBUTIONS 
821 Electrocardiographic Insights Into 
Cardiac Physiology 
Monday, March 31, 2003,2:00 p.m.-3:30 p.m. 
McCormick Place, Room S404 
2:oo p.m. 
821-l Autonomic Modulation of the lJ Wave 
Anthonv R. Maonana Sarah Suleman, Daniel M. Bloomfield, Columbia University New 
York Presbyterian Medical Center, New York, NY 
Background: Increasing evidence supports the hypothesis that U waves visible on the 
electrocardiogram (ECG) of normal individuals may be caused by afterdepolarizations 
(AD). Catecholamines are known to increase the amplitude of both ADS and U waves. 
Beta-adrenergic blockade decreases AD amplitude while alpha-adrenerglc stimulation in 
intact animals increases AD amplitude, but their effects on the U wave are unknown. 
Methods: 25 normals underwent esmolol (1mgJkg. then 0.05 mglkglmin) and phenyleph- 
rme infusion (1.4+0.2mcg/kgimin). Heart rate (HR), T & U wave amplitude, and QT & QU 
intervals were measured using QT-Guard at baseline and during drug infusions. Among 
24 subjects with U waves on their resting ECG, baseline values were compared with 
those during drug infusion by paired t-tests. 
Results: As expected. HR decreased with both interventions (p<O.OOl). Mean U wave 
amplitude increased by 16.3% during phenylephrine (from 83.0 I.IV lo 96.5pV, p<O.OOl), 
but decreased by 14.5% during esmolol (from 83.8pV to 71.61@, pcO.001) (figure). 
Mean T wave amplitude increased from 597pV to 692MV with phenylephrine (p<O.OOl) 
but decreased from 632pV to 568pV with esmolol (p<O.OOl). QT & QU intervals 
increased with both interventions (p<O.OOl). 
Conclusions: U wave amplitude is highly dependent upon autonomic state. The obselva- 
tions that catecholamines, beta-blockade and alpha-adrenergic stimulation modify ADS 
and U waves in a similar manner suggest that U wave amplitude may be an ECG refkc- 
tion of AD amplitude 
821-2 
2:15 p.m. 
Gender Differences in Cardiac Repolarization of the 
Human Transplanted Heart 
Subhashln A. Gowda, Steven A. Rothman, Temple University, Philadelphia, PA 
BACKGROUND: Hormonal and autonomic influences have been proposed to be respon- 
sible for the differences I” cardiac repolarisation between men (M) and women (F) as 
manifested by the longer ECG OTC interval in F. To evaluate the effects of hormones, we 
compared the changes in cardiac repolarization from pre- to post cardiac transplantation 
(OHT) of the donor heart in transgender and same gender recipients. METHODS: ECGS 
were analysed in 100 OHT patients: 42 transgender (26 F to M and 16 M to F) and 58 
same gender (8 F to F and 50 M to M). The donor QTc was measured prior to explanta- 
tion and then again following OHT at regular intervals comparing the change in QTc. Dif- 
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ferences in QTc intewls between M and F OHT recipients were also compared. 
RESULTS: In the early post OHT period, there was a significant decrease in the QTc 
interval for the F to M transplantation subgroup which persisted throughout follow-up. 
QTc Changes Following Transplant&on 
Group (Donor to Recipient) 2 days 1 week 1 month 1 year 
MtoM -15*66 2+38 -6*46 1*40 
MiuF 2252 -4i27 0+35 8*28 
F to F -15*49 -6+33 -37+1* &31 
F to M -42r36 -23*18 -16212’ -24*22’ 
* = p &amp;amp:lt; 0.05 for change in QTc 
When comparing the QTC among M and F recipients, there was no gender difference in 
the QTc interval at early follow-up (419+27 YS 420 +23 for M vs Fat 1 week; 416231 vs 
415a23 at 1 month), but a significant 
(p&amp;amp;amp;amp;amp;amp;amp;amp:amp;lt;O.O5) difference at late follow-up 
(417t26 vs 432+26 for M YS Fat 1 year; 429*30 vs 450*25 at >2 year follow-up). CON- 
CLUSIONS: Gender related QTc changes are evident both immediately and late after 
OHT. These effects are most consistent with a hormonal etiology and probably not due to 
autonomic influences. 
2:30 pm 
821-3 SCNSA Mutations in the S5-S6 Region Cause Srugada 
Syndrome and Cardiac Conduction Disturbances 
Hideki ltoh Masami Shimizu, Hiroshi Mabuchi, Graduate School of Medical Science, -I 
Kanazawa University, Kanazawa, Japan 
Background: The SCNBA gene encoding the alpha subunit of the human cardiac sodium 
channel plays a key role in cardiac electrophysiology. Mutations in SCN5A lead to a wide 
variety of phenotypes, including long QT syndrome, Brugada syndrome, and isolated 
progressive cardiac conduction defects. Clinically. there appears to be some overlap 
among these syndromes, as all are associated with a relatively high incidence of noctur- 
nal sudden cardiac death without prior symptoms. 
Methods: DNA was isolated from peripheral white blood cells of 40 patients with Brugada 
syndrome in Japan and analyzed SCNBA mutations by PCR-SSCP and direct sequence 
methods. 
Results: We detected 2 point mutations in the SCN5A gene (Arg282His and Asn406Ser). 
These mutations was not detected in 200 chromosomes of normal controls and sug- 
gested as disease causing mutations. In a 51 year-old man with frequent nocturnal poly- 
morphic ventricular tachycardra, we found the Arg282His mutation in the SS-pore region 
of domain I. He had a 36-year-old brother who suffered sudden death. We analyzed 5 
family members and detected 3 of the Arg282His mutation carriers and 2 noncarriers. 
The 2 noncarriers had neither aborted sudden death nor electrocardiographic changes. 
Two of the mutation carriers, excluding the proband, had no syncope or ventricular fibril- 
lation. All 3 mutation carriers had ST-segment elevations in leads Vl to V2N3. Two of 
the mutation carriers, excluding the proband. had ST-segment elevations and a widened 
QRS complex. The PO and QT intervals in all of the patients with the Arg282His mutation 
were normal. In a 67 year-old man with asymptomatic Brugada syndrome, we found the 
Asn406Ser mutation in the S6 segment of domain I. He had 21 year-old father and 27 
year-old cousin with sudden death. Proband with the Asn406Ser mutation had not only 
ST-segment elevation but bradycardia, first degree of atrioventricular block, and prolon- 
gation of the QRS width. 
Conclusions: We suggested SCN5A mutations in the S5-S6 region cause both Brugada 
syndrome and cardiac conduction disturbances. Both mutations are located in important 
sites in the Sbpore or S6 segment that confer ion selectivity and mutations might cause 
serious clinical phenotypes. 
2:45 p.m. 
821-4 Cardiac Autonomic Modulation by Estrogen in Female 
Mice Undergoing Ambulatory Monitoring and In Yivo 
Electrophysiologic Testing 
Samir Saba, Vladimir Shusterman, lrmute Usiene, Barry London, University of 
Pittsburgh, Pittsburgh, PA 
Introduction: Estrogen is an impoltant modulator of cardiovascular risk, but its mecha- 
nism of action is not fully understood. In this study, we investigated the effect of ovariec- 
tomy and its timing on the cardiac electrophysiology (EP) in female mice, with and 
without autonomic blockade. Methods: Thirty female mice (age 16.6+ 3.1 weeks) “nder- 
went blinded in viva EP testing before and 10 minutes after administration of atropine 
(0.5 mglkg, IP) and propranolol (1 mglkg, IP). Fifteen mice were ovariectomized pre- 
puberty (PRE) and 10 post-puberty (POST), 2 weeks prior to EP testing. Five sham-oper- 
ated female mice (F) served as controls. A subset of 19 mice (5 PRE, 3 POST, and 5 F) 
underwent 24.hour ambulatory monitoring prior to the EP testing. Uteri from all mice 
were surgically removed and weighed. Results: With ambulatory monitoring, the aver- 
age (668+ 28 versus 769* 52 b/min, p=O.OOS) and minimum (485* 47 versus 587+ 53 b/ 
mm, p=O.OZ) heart rates were significantly slower in the ovariectomized mice (PRE and 
POST groups) compared to the F group. At baseline EP testing, there were no significant 
differences between the ovariectomized and intact mice in any of the measured parame- 
ters. With autonomic blockade, the F group had a significantly larger change (A ) in the 
atrioventricular (AV) nodal Wenckebach (AVW) periodicity (A AVW = 11.3* 2.9 versus 
2.1 t 7.3 ms, p=O.O5) and functional refractory period (A FRP = 11.3+ 2.1 versus 1.25* 
6.8 ms, p=O.O2) compared to the ovariectomized mice. These results were not altered by 
the time of ovarlectomy (PRE versus POST groups). The weights of the uteri were signif- 
icantly different among the 3 groups (14.3t 6.7 mg, 23.5* 10.6 mg, 68.5+ 17.7 mg for the 
PRE, POST and F groups respectively, ~~0.05 for all comparisons). Conclusion: Our 
results suggest that estrogen modulates the autonomic inputs into the murine sinus and 
AV nodes. Low estrogen states, regardless of the time of ovariectomy, decrease the 
autonomic influence on the heart. These findings, if replicated in humans, might underlie 
the observed clustering of certain arrhythmias around menstruation and their higher inci- 
dence in men and post-menopausal women. 
3:00 p.m. 
821-5 Validation of Electrocardiogram Criteria for Pulmonary 
Hypertension 
Khalid Al-Naamani Thao Huynh, S. Andrew, McGill University Health Center, Montreal, 
PQ, Canada 
Background Measurement of right ventricle systolic pressure (RVSP) by PD-echocar- 
diography (echo) had been shown to have good correlation with value obtained by car- 
diac catheterization. We aimed to validate the sensitivity, specificity and predictive values 
of electrocardiography in patients with elevated RSVP diagnosed by PD-echocardio- 
graphy. 
Methods We analyzed all patients who had echo and EKG, withm a l-month interval, at 
our institution during 2000-2001. The following criteria were studied. 
7) R wave in V1>7mm or2)R wave in V5<5mm or3) R wave in lead 1<2mm or 4)RSr in 
Vl with R>l Omm w 5) S wave in V6>7mm or6) S wave in V1<2mm or 7) R/S in Vl >l cy 
8) WS in V6<1; 3 RVl+SVS or 10) SV6810 mmor RAD>llOor qR in Vl. Significant pul- 
monary hyperlension was defined as RVSP240 mm Hg by 2-D Echo and no pulmonary 
stenosis. 
Results There were 365 patients with EKG and echo within a l-month interval. We 
excluded all patients with paced rhythm and poor EKG quality. The above criteria have 
very poor sensitivity (0.0% to 13%), negative predictive values (24% to 36%). They had 
excellent specificity (92% to 100%) with positive predictive values ranging from 64% to 
100%. 
Although highly specific, these criteria have poor sensitivity and negative predictive val- 
“es. 
Conclusion The currently available EKG criteria are poorly 
sensitive for significant pulmonary hypertension. New EKG 
criteria with better sensitivity should be developed. 
Sensitivity % Specificity % + Predictive Value% - Predictive Value % Accuracy % 
2.55 96.7 63.6 24.5 25.8 
13.45 93.3 30.8 26.3 32.2 
8.0 94.4 61.5 25.1 29.3 
0.01 100 100 24.8 25.2 
1.8 98.9 83.3 24.8 25.7 
4.0 100 100 25.4 27.7 
7.0 3.3 86.4 35.0 29.0 
2.9 2.2 60.0 24.8 26.3 
1.1 2.2 60.0 24.4 24.9 
8.0 3.3 88.0 25.6 29.9 
5.6 3.3 84.2 35.4 28.2 
10.2 7.8 80.0 25.2 30.4 
3:15 p.m. 
621-6 Increased Levels of High-Sensitivity C-Reactive Protein 
Are Associated With a Longer QTc Interval in 
Apparently Healthy Subjects 
Aria P. Yazdanbakhsh, Bojan Vrtovec, Branislav Radovancevic. Todd T. Schlegel. NASA 
Johnson Space Center, Houston, TX 
Background. QTc interval prolongation is associated with an increased risk of cardio- 
vascular moltality in apparently healthy individuals. Furthermore, healthy subjects with 
increased levels of high-sensitivity C-reactive protein (hsCRP) are at a higher risk of car- 
diovascular disease. Whether increased levels of hsCRP are associated with a longer 
QTc intswal has not yet been studied. Methods. In 110 (56 male/ 54 female) healthy vol- 
unteers with a mean age of 36 + 11 (range 20-65) years, mean QT interval was mea- 
sured from a standard 12-lead ECG and QTc interval duration was calculated with the 
Bazett formula. At the time of ECG recordings, plasma levels of hsCRP were measured 
using the Kaimaya assay. Cardiovascular risk stratification included assessment for the 
presence of hypertension, smoking, and diabetes mellitus; and measurement of serum 
cholesterol, LDL, and HDL levels. The lo-year coronary disease risk was calculated 
according to Framingham risk estimates. Results. The overall mean QTc intewal was 
399 + 25 ms (range: 321 - 469 ms), and the mean hsCRP level was 0.195 + 0.364 mg/dl 
(range: 0.002 - 2.517 mg/dl). Out of 110 subjects, 48 (43%) had an hsCRP level > 0.12 
mg/dl. and 62 (57%) had an hsCRP level < 0.12 mg/dl. The subjects with hsCRP > 0.12 
mg/dl had a significantly longer QTc interval than those with hsCRP < 0.12 mg/dl (405 f 
23 ms vs. 392 + 25 ms, p=O.O18). In multivariate analysis. hsCRP level > 0.12 mg/dl was 
associated with significantly longer QTc intewal (p=O.O47). No other differences in car- 
diovascular risk factors between the high-hsCRP and low-hsCRP groups were found. 
